Navigation Links
Failure of heart drug offers lessons for drug industry

Madison, Wis. - Pfizer spent about $800 million to develop torcetrapib, a heart drug that seemed like a blockbuster until people began to die in clinical trials. Hours after learning the drug was irreversibly flawed, the company called a halt to further trials, a decision that sent its stock downward and put thousands of job......

Full article >>> elatively few useful drugs.

Tufts luck

Consider a recent study by Tufts University, which examined the cost of producing biotechnology drugs. Unlike prescription drugs that are made with synthetic chemicals, biotech drugs are derived from substances occurring naturally in the human body or in other living organisms. This is a sweet spot f......

Full article >>> at may be the first major contribution of human embryonic stem cell research. Animal tests generally work well, but tests employing stem cells and biomarkers could dramatically increase accuracy - and weed out dangerous drugs earlier.

That's not to say drugs will ever be cheap so far as consumers are concerned. The search for new medicines is a process that will continue to be costly, mai......

Full article >>>
'"/> By Tom Still 12/12/06

Related biology technology :

1. Router Failure and Software Crash UW-Madison Network
2. Primary cells, rat heart endothel
3. Primary cells, rat heart muscle
4. UW tests adult stem cell role in regenerative heart care
5. InvivoSciences receives NIH grant for heart technology
6. FDA approves GEs heart-imaging technology
7. Biotech firm uses live heart tissue in drug screens
8. Aurora team implants Wisconsins first total artificial heart
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. UW-Madison puts heart and mind into stem cells
11. Technology helps heal heart arrhythmias in children
Post Your Comments:

(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/26/2015)... 26, 2015 --> ... in imaging technologies, announced today that it has received a ... the Horizon 2020 European Union Framework Programme for Research and ... trial in breast cancer. , --> ... --> --> The study aims to ...
(Date:11/25/2015)... India , November 26, 2015 ... The Global Biobanking Market 2016 - 2020 report ... by maintaining integrity and quality in long-term samples, ... enabling long-term cost-effectiveness. Automation minimizes manual errors such ... the technical efficiency. Further, it plays a vital ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
Breaking Biology Technology:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/20/2015)... -- NXTD ) ("NXT-ID" or the "Company"), ... commerce market and creator of the Wocket® smart wallet, ... interviewed on The RedChip Money Report television ... Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, and ... ) ("NXT-ID" or the "Company"), a biometric authentication company ...
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
Breaking Biology News(10 mins):